MOA Bosentan
BosENtan
competitively inhibits ENdothelin-1 receptors to reduce pulmonary vascular resistance
AE: Hepatotoxicity
Voluntary social withdrawal
Limited emotional expression
Content with social isolation
dx?
Schizoid PD (Cluster A)
Hypersensitive to rejection Socially inhibited Timid Feelings of inadequacy Desires relationships with others
Avoidant PD
Left-dominant coronary circulation
PDA arises from LCX (8%)
Chlorpheniramine
Class
Antihistamine
Reversible inhibitor of H1 receptor
AE: drowiness, antimuscarinic, anti-alpha adrenergic
Major substrate for renal ammoniagenesis
Glutamine
Cool, pale extremities elevated JVP Crackles over bottom lung fields weak peripheral pulses Kind of shock?
Cardiogenic
Case control vs cohort studies
Case-control: disease/no disease
Cohort: exposure/no exposure